| |
| |
|
| Insider
Information: |
Berman Michael A |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
39,965 |
|
|
Indirect Shares
|
5,410 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
45,375 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cadence Pharmaceuticals Inc |
CADX |
Director |
2011-05-12 |
39,965 |
2011-05-12 |
5,410 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2011-05-12 |
5 |
GA |
$0.00 |
$0 |
I/I |
1,000 |
1,000 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2011-05-12 |
5 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
39,965 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2010-05-18 |
5 |
D |
$0.00 |
$0 |
I/I |
(3,265) |
0 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2010-05-18 |
5 |
A |
$0.00 |
$0 |
D/D |
3,265 |
40,965 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2009-08-18 |
4 |
A |
$9.94 |
$9,940 |
D/D |
1,000 |
37,700 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2009-08-17 |
4 |
A |
$10.12 |
$10,115 |
D/D |
1,000 |
36,700 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2009-05-20 |
4 |
A |
$9.57 |
$5,506 |
I/I |
575 |
1,090 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2009-05-18 |
4 |
A |
$9.58 |
$78,533 |
D/D |
8,200 |
31,500 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2008-05-16 |
4 |
B |
$6.24 |
$32,844 |
I/I |
5,200 |
900 |
2.1 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2008-05-16 |
4 |
B |
$6.33 |
$24,054 |
D/D |
3,800 |
23,300 |
2.39 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2008-05-15 |
4 |
B |
$6.22 |
$622 |
I/I |
100 |
100 |
2.02 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2008-05-15 |
4 |
B |
$6.10 |
$6,100 |
D/D |
1,000 |
19,500 |
2.39 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2008-03-17 |
4 |
B |
$4.90 |
$53,745 |
D/D |
10,000 |
18,500 |
2.39 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2006-12-15 |
4/A |
B |
$12.17 |
$60,837 |
D/D |
5,000 |
8,500 |
2.39 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2006-12-15 |
4 |
B |
$12.17 |
$60,837 |
D/D |
5,000 |
33,500 |
2.39 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2006-12-14 |
4/A |
B |
$12.50 |
$31,250 |
D/D |
2,500 |
3,500 |
2.39 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2006-12-14 |
4 |
B |
$12.50 |
$31,250 |
D/D |
2,500 |
28,500 |
2.39 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2006-11-01 |
4/A |
B |
$9.54 |
$5,724 |
I/I |
600 |
300 |
2.1 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2006-11-01 |
4/A |
B |
$9.45 |
$9,450 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
Director |
– • – |
2006-11-01 |
4 |
B |
$9.45 |
$9,450 |
D/D |
1,000 |
26,000 |
2.39 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
